BLSM NASDAQ
BlossomHill Therapeutics, Inc.
1W: -0.3%
1M: +1.6%
YTD: +23.1%
$19.69
+1.10 (+5.92%)
Weekly Expected Move ±16.7%
$13
$16
$20
$23
$26
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$572.6M
52W Range15.25-27.99
Volume169,323
Avg Volume261,453
Beta0.00
Dividend—
Analyst Ratings
Company Info
CEOJing Rong Jean Cui
Employees63
SectorHealthcare
IndustryBiotechnology
IPO Date2026-08-07
Websitebhtherapeutics.com
10255 Science Center Drive, Suite 200
San Diego, CA 92121
US
San Diego, CA 92121
US
About BlossomHill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
Latest News
BlossomHill Therapeutics (NASDAQ:BLSM) Shares Down 4.9% – Time to Sell?
BlossomHill Therapeutics (NASDAQ:BLSM) Shares Gap Up – Here’s Why
BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer
HC Wainwright Brokers Reduce Earnings Estimates for BLSM
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
Recent Insider Trades
No insider trades found